Small Molecule Drug Discovery for Ebola Virus Disease

Q: What type of study is this?

This is a Drug Discovery study.

D. Durante; V. Murugesh; Tyler Kalanquin; Irina N. Gaisina; Lijun Rong; Terry W. Moore

doi:10.1039/d5md00533g

January 1, 2025RSC Medicinal ChemistryOpen Access

Small Molecule Drug Discovery for Ebola Virus Disease

View Full Paper

Ask AI

Bookmark

Share

Key Points

New small molecule approaches show promise in combating the Ebola virus, improving future treatment options.
Recent Ebola outbreaks from 2021 to 2025 highlight the need for effective drug strategies against this filovirus.
Targeted drug discovery methods are being developed to specifically address the challenges posed by Ebola virus infection.
This ongoing threat calls for urgent advancements in filovirus therapeutics, potentially reducing the impact of future epidemics.

Implication

Research uncovers potential small molecule therapies for Ebola virus, suggesting new intervention strategies against outbreaks.

Abstract

Known for its widespread outbreaks, including the 2013–2016 epidemic that resulted in around 11 300 deaths, Ebola virus (EBOV) and related filoviruses remain a current threat as consecutive filoviral outbreaks have occurred between 2021 through 2025.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Durante et al. (2025) studied this question.

synapsesocial.com/papers/68c1bd2a54b1d3bfb60edeae https://doi.org/10.1039/d5md00533g

View Full Paper

Ask AI

Bookmark

Share

Small Molecule Drug Discovery for Ebola Virus Disease

Key Points

Implication

Abstract

Discussion

Cite This Study

Small Molecule Drug Discovery for Ebola Virus Disease

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading